Virax Biolabs Group Limited (NASDAQ:VRAX) announced on Tuesday that it had signed a Research Services Agreement (RSA) with ...

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Thyroid Cancer Pipeline Report to explore emerging ...

Diverse patient groups are notably absent in systemic lupus erythematosus clinical trials whereas white patients are overrepresented, according to a study published in Arthritis Care & Research. Black ...

Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging ...

Jyong Biotech (MENS) announced its participation in the 22nd Urological Association of Asia Congress which was held in conjunction with the 47th ...

As questions about LASIK eye surgery continue to surface in public discussions and media coverage, Brinton Vision has released a new in-depth article titled “Is LASIK Safe? A 2025 Update Backed By New ...

THL Partners has announced its agreement to purchase Headlands Research, a clinical trial sites network, from KKR-managed ...

ADA 2025 | Laekna Presented Clinical and Pre-clinical Studies Results of LAE102, LAE103 and LAE123 Provided by Business Wire Jun 23, 2025, 5:30:00 AM ...

uniQure Presents Clinical Case Study of First Patient Dosed with AMT-260 in Refractory Mesial Temporal Lobe Epilepsy (MTLE) ...

The leading Hereditary Angioedema Companies such as Corcept Therapeutics, BioCryst Pharmaceuticals, KalVista Pharmaceuticals, ...

The first participant in the GenTLE clinical trial has been followed for five months post-administration of AMT-260.